Breast, Prostate Cancer Common in Patients With COVID-19 and Cancer History
For patients hospitalized with COVID-19, prostate cancer was the most common cancer type across all databases.
Lung Cancer
Increased Respiratory Tract Cancers Linked to Low Sociodemographic Index
An analysis of the 2019 Global Burden of Disease Study offers insight into rates and risk factors for respiratory tract cancers globally, regionally, and nationally.
Method May Enable Noninvasive Lung Cancer Detection
The method involves DELFI, an approach that can detect many abnormalities in cfDNA through genome-wide analysis of fragmentation patterns.
Handheld Fan Effective Nonpharmacologic Strategy for Dyspnea in Lung Cancer
Turkish researchers sought to measure the effects of this strategy on FTP, ABG, and quality of life in patients with lung cancer.
Exkivity Approved for EGFR Exon 20 Insertion+ NSCLC
Exkivity (mobocertinib) is approved to treat adults with locally advanced or metastatic NSCLC with EGFR exon 20 insertion mutations whose disease has progressed on or after platinum-based chemotherapy.
Model More Accurately Predicts Outcomes of Radiotherapy in Cancer Patients
The genomic-adjusted radiation dose (GARD) model predicts outcomes of radiotherapy.
Study Reveals Lack of Adherence to Treatment Guidelines in Non-Small Cell Lung Cancer
Patient age, treatment center, and tumor size were associated with a lack of adherence.
Large Study Shows ‘Disappointing’ Treatment Responses in NRG1 Fusion-Driven Lung Cancers
The highest response rate observed with any therapy was 25%.
Changes in Clinical Trial Conduct Prompted by the COVID-19 Pandemic Should Persist
The AACR COVID-19 and Cancer Task Force recommends keeping changes to clinical trial practices that were prompted by the pandemic.
Second-Line Immunotherapy May Improve Survival in Mesothelioma
Immune checkpoint inhibitors prolonged survival when compared with chemotherapy.
- Loading...
Loading...
Next post in News
Loading... 
Loading...